SCHEMBL6026684

SCHEMBL6026684

O=C(Cl)c1sc2cc(F)c(OC(F)(F)F)cc2c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STING1 Q86WV6 1/20 0.40
▸ BCKDK O14874 2/20 0.40
▸ RXFP1 Q9HBX9 2/20 0.37
▸ PRNP P04156 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ PPARG P37231 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ MAPK10 P53779 1/20 0.37
▸ NCOA2 Q15596 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ MCL1 Q07820 2/20 0.37
▸ BCL2L1 Q07817 1/20 0.37
▸ EPHX2 P34913 1/20 0.37
▸ LMNA P02545 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ GAA P10253 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ RAB9A P51151 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6025520 0.85 STING1 (0.52) STING1BCKDKRXFP1PRNPTSHR
SCHEMBL20695331 0.84 BCKDK (0.52) STING1BCKDKRXFP1PRNPTSHR
SCHEMBL3063440 0.81 BCKDK (0.49) STING1BCKDKRXFP1PRNPTSHR
SCHEMBL694056 0.80 BCKDK (0.43) STING1BCKDKRXFP1PRNPTSHR
SCHEMBL6840242 0.77 MCL1 (0.45) STING1BCKDKRXFP1PRNPTSHR
SCHEMBL1254412 0.75 MCL1 (0.51) STING1BCKDKRXFP1PRNPTSHR
SCHEMBL1609773 0.75 STING1 (0.65) STING1BCKDKRXFP1PRNPTSHR
SCHEMBL6025665 0.73 BCKDK (0.56) STING1BCKDKRXFP1PRNPTSHR
SCHEMBL6026258 0.72 STING1 (0.51) STING1BCKDKRXFP1PRNPTSHR
SCHEMBL5227841 0.71 STING1 (0.53) STING1BCKDKRXFP1PRNPTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664037-A1 HALO SUBSTITUTED BENZO [B] THIOPHENES WITH PI3K INHIBITORY ACTIVITY AS THERAPEUTIC AGENTS WARNER-LAMBERT COMPANY LLC (US) 2006-06-07 — — EP disclosed
US-20050096350-A1 Halo substituted benzo[b]thiophenes as therapeutic agents CONNOLLY MICHAEL K (US) 2005-05-05 — — US disclosed
WO-2005023800-A1 HALO SUBSTITUTED BENZO`B! THIOPHENES WITH PI3K INHIBITORY ACTIVITY AS THERAPEUTIC AGENTS WARNER-LAMBERT COMPANY LLC (US) 2005-03-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050096350-A1 Halo substituted benzo[b]thiophenes as therapeutic agents HCLS1, BRI3BP, BRPF1 STING1 2297/4885BCKDK 2044/4885RXFP1 257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback